Dermaliq Therapeutics locks in $15m Series A
Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.
18 January 2022•1 min read
Dermaliq Therapeutics Inc, a new Delaware-based pharmaceutical development company, has raised $15 million in Series A financing.